Skip to main content

Animations

MJFF Publications

The Michael J. Fox Foundation continually strives to communicate our scientific progress with the research community — through posters and presentations at meetings, in peer-reviewed scientific publications and with white paper reports.

From
To
  • Default content image

    Associations Between Brain Microstructural and Dopaminergic Integrity in Parkinson’s Disease: A Joint Diffusion Tensor and DAT Imaging Study

    Movement Disorder Society - Dublin, Ireland Objective: To determine whether regional variations in brain microstructural integrity are associated with (a) dopaminergic integrity of the striatum and …
    Learn more

  • Default content image

    Frequency of Impulse Control Disorder Symptoms in De Novo Parkinson Disease Patients and Healthy Controls

    Movement Disorder Society - Dublin, Ireland Objective: To determine the frequency of impulse control disorder (ICD) symptoms and related behaviors in a cohort of de novo, untreated Parkinson disease…
    Learn more

  • Default content image

    Association Between CSF Biomarkers and Clinical Phenotype of Early Parkinson’s Disease in the Parkinson’s Progression Marker Initiative (PPMI)

    Movement Disorder Society - Dublin, Ireland Background: There is substantial heterogeneity in the onset and progression of clinical phenotypes of Parkinson's disease (PD) such as cognitive…
    Learn more

  • Default content image

    Diurnal and Intersubject Variability of Cerebrospinal Fluid Biomarkers in Parkinson’s Disease and Healthy Volunteers

    Movement Disorder Society - Dublin, Ireland Objective: To determine the diurnal fluctuations of specific biomarkers alpha-synuclein, DJ-1, and several amyloid beta species in the cerebrospinal fluid…
    Learn more

  • Default content image

    Baseline Neuroimaging Characteristics of the Parkinson’s Progression Marker Initiative (PPMI) Parkinsons and Healthy Cohorts

    Movement Disorder Society - Dublin, Ireland Objective: The Parkinson's Progression marker initiative (PPMI) is a multicenter, international, longitudinal study evaluating clinical, biochemical, and…
    Learn more

  • Default content image

    Novel Tools for LRRK2 Research

    World Pharma Congress - Philadelphia Mutations in LRRK2 represent the most frequently found genetic factors yet discovered for PD and its role as a putative kinase, combined with the fact that…
    Learn more

  • Default content image

    Repositioning Drugs for Parkinson’s Disease

    World Pharma Congress - Philadelphia Drug repositioning refers to applying an existing compound (either an approved drug or a clinical candidate in testing) for one indication to another indication…
    Learn more

Articles authored by Rachel Dolhun, MD, a movement disorder specialist on staff at MJFF, offer a practical review of topics related to Parkinson's disease for practicing clinicians.

From
To

No results were found.

Female researcher pipetting in lab.

Breaking Research Updates

Read the latest developments in the field’s understanding and treatment of Parkinson’s disease.

Read Research News
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.